Search

On the occasion of World Pneumonia Day, we interviewed Juanjo Infante, CEO of Vaxdyn, a biotech company developing the K-Vax vaccine candidate against Klebsiella pneumoniae, which is responsible for

We interviewed Christine Kolland, Business Development Iberia & Latin America at ZETA, Bronze Sponsor of the Green Innovation Forum

In this article, Chus Castillo, Partner Consulting Iberia at Alira Health, and Ion Arocena, General Manager at AseBio, explore the innovative therapies landscape in Spain, existing barriers, and

We interviewed Iñaki Larraya, Managing Director of Sodena, the public entity of the Government of Navarra organizing the upcoming edition of the Green Innovation Forum in Pamplona alongside AseBio.

In its 12th edition, the event is expected to gather over 2,000 professionals from more than 1,000 organizations working in health, agri-food, and sustainable industrial solutions from October 7 to 9

The agreement was unveiled at this year’s BIO Europe, which is the largest partnering event for the biomedical industry in Europe, taking place this week in Stockholm. Over 2,800 companies attended

The Green Innovation Forum 2024 is a must-attend event for companies, foundations, and academic institutions in the biotechnology field, as well as for companies and institutions from other industrial

El pasado 24 de octubre, Mikrobiomik celebró su primer Investor´s Day, reuniendo a profesionales del sector farmacéutico y biotecnológico, socios e inversores. En la jornada se compartieron logros

The new SunLabs facility will be a cutting-edge life sciences research and development hub.

VC funding led by imec.xpand, with significant participation from the EIC Fund (venture arm of the European Innovation Council) and continued support from existing investors Asabys Partners and Aliath

The organisations are collaborating on two studies in the field of severe Legionella infections and antibiotic resistance.

Final data from PORTICO, global Phase IIb vafidemstat trial in BPD,presented at the 37th ECNP annual conference in September

These data consolidate the Barcelona Science Park as one of the most powerful hubs for public innovation in health in Europe and reaffirm its role as a key player in the advancement of socio-economic

Agarose Bead Technologies has enhanced its Burgos facility by boosting its agarose resin production to 100,000 liters annually to position itself as a powerhouse in the novel therapies market.

Spanish company Quibim's QP-Prostate solution, which uses biopsy and MRI data for training, achieves higher accuracy than traditional methods.

ATX-01 is the industry’s first anti-microRNA therapeutic to be investigated in DM1